Trial intelligence / Profile preview

COPMAN: Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery

NCT04139655Withdrawn

Sponsor
University of British Columbia
Start
Sep 2020
Primary completion
Sep 2021
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, double-blind trial in Myocardial injury comparing Colchicine Group with Placebo Group (2 arms). Primary endpoint: Number of Patients Recruited at 3 months. Planned start Sep 2020; status: withdrawn.

02

Drugs

colchicine
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT04139655.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04139655.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call